COLUMBIA, Md., Aug. 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it is presenting at the 26th annual Canaccord Adams Summer Seminar in Boston, MA. The conference is being held August 8-10, 2006 at the Boston Marriott Long Wharf. Steve Dubin, President and CEO, and Peter L. Buzy, CFO, will be presenting on Thursday, August 10th, at 10:30 a.m. Eastern Time.
A live audio webcast of Martek’s presentation will be available by accessing the following link: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=MATK&item_id=1351748
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults
Investor Relations (410) 740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations of Martek BiosciencesCorporation, +1-410-740-0081
Web site: http://www.martek.com/
